Synonyms Peripheral T-cell lymphoma unspecified refractory, Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, Refractory Unspecified Peripheral T-Cell Lymphoma + [2] |
Introduction Peripheral T-cell lymphoma, not otherwise specified that is resistant to treatment. |
Target |
Mechanism HDAC inhibitors |
Active Org. Acrotech Biopharma LLCStartup [+2] |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date03 Jul 2014 |
Target |
Mechanism KIR3DL2 antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CDK9 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Feb 2024 |
Sponsor / Collaborator |
Start Date24 May 2021 |
Sponsor / Collaborator |
Start Date14 Apr 2021 |
Sponsor / Collaborator |